Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

$708.6B

Market Cap • 4/3/2025

1901

(124 years)

Founded

1970

(55 years ago)

IPO

NYSE

Listing Exchange

Flag of US

Indianapolis

Headquarters • Indiana

S&P500 Participant

Index Composite • 2025